open access

Online first
Editorial
Published online: 2022-01-04
Get Citation

Coronary sinus Reducer — an adjunctive tool for the treatment of patients with RCA CTO

Maayan Konigstein1
DOI: 10.33963/KP.a2022.0001
·
Pubmed: 34981825
Affiliations
  1. Division of Cardiology, The Tel-Aviv Sourasky Medical Center and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

open access

Online first
Editorial
Published online: 2022-01-04

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Coronary sinus Reducer — an adjunctive tool for the treatment of patients with RCA CTO

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Editorial

Published online

2022-01-04

DOI

10.33963/KP.a2022.0001

Pubmed

34981825

Authors

Maayan Konigstein

References (10)
  1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 . Lancet. 2016; 388(10053): 1459–1544.
  2. Crea F, Merz CB, Beltrame J, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J. 2019; 40(29): 2455–2462.
  3. Abdallah MS, Wang K, Magnuson EA, et al. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. J Am Coll Cardiol. 2017; 69(16): 2039–2050.
  4. Konigstein M, Giannini F, Banai S. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives. European Heart Journal. 2017; 39(11): 925–933.
  5. Verheye S, Agostoni P, Giannini F, et al. Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study). EuroIntervention. 2021; 17(7): 561–568.
  6. Ponticelli F, Khokhar A, Leenders G, et al. Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study. International Journal of Cardiology. 2021; 337: 29–37.
  7. Verheye S, Jolicœur E, Behan M, et al. Efficacy of a device to narrow the coronary sinus in refractory angina . N Engl J Med. 2015; 372(6): 519–527.
  8. Zivelonghi C, Verheye S, Timmers L, et al. Efficacy of coronary sinus reducer in patients with non-revascularized chronic total occlusions. Am J Cardiol. 2020; 126: 1–7.
  9. Mrak M, Pavšič N, Ponticelli F, et al. Efficacy of coronary sinus reducer implantation in patients with chronic total occlusion of the right coronary artery. Kardiol Pol. 2022; 80(1): XXX–XXX.
  10. Maria GDe, Alkhalil M, Borlotti A, et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction – Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study). EuroIntervention. 2018; 14(3): e352–e359.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl